MoneyWorks4Me

Alembic Pharmaceuticals informs about outcome of board meeting

20 Jul 2017 Evaluate

Alembic Pharmaceuticals has informed that the Board of Directors of the company at its meeting held today has approved the Unaudited Financial Results for the quarter ended on 30th June, 2017.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..